The Ets‐1 and Ets‐2 transcription factors activate the promoters for invasion‐associated urokinase and collagenase genes in response to epidermal growth factor

Urokinase plasminogen activator (uPA) has been associated with invasion and metastasis in breast cancer. The expression of uPA and 92 kDa type IV collagenase (gelatinase B/MMP‐9) is regulated by growth factors, receptor‐type tyrosine kinases and cytoplasmic oncoproteins. Here, we have identified tra...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of cancer 1998-07, Vol.77 (1), p.128-137
Hauptverfasser: Watabe, Tetsuya, Yoshida, Koichi, Shindoh, Masanobu, Kaya, Mitsunori, Fujikawa, Keiko, Sato, Hiroshi, Seiki, Motoharu, Ishii, Seiichi, Fujinaga, Kei
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 137
container_issue 1
container_start_page 128
container_title International journal of cancer
container_volume 77
creator Watabe, Tetsuya
Yoshida, Koichi
Shindoh, Masanobu
Kaya, Mitsunori
Fujikawa, Keiko
Sato, Hiroshi
Seiki, Motoharu
Ishii, Seiichi
Fujinaga, Kei
description Urokinase plasminogen activator (uPA) has been associated with invasion and metastasis in breast cancer. The expression of uPA and 92 kDa type IV collagenase (gelatinase B/MMP‐9) is regulated by growth factors, receptor‐type tyrosine kinases and cytoplasmic oncoproteins. Here, we have identified transcriptional requirements for the induction of uPA and 92 kDa type IV collagenase by epidermal growth factor (EGF). EGF stimulates the motile and invasive activities specifically in the ErbB‐2‐overexpressing SK‐BR‐3 cells. Expression of extracellular matrix‐degrading proteases including type I collagenase/MMP‐1, 92 kDa type IV collagenase/MMP‐9, uPA and uPA receptor were induced. EGF also transiently stimulated expression of the transcription factors Ets‐1 and Ets‐2. Reporter transfection assays revealed the activation of uPA and MMP‐9 collagenase promoters by EGF and the requirement of each of the composite Ets and AP‐1 transcription factor binding sites for an EGF response. Most notably, transfections with the Ets‐1 and Ets‐2 expression vectors potentiated uPA and MMP‐9 promoter activation in response to EGF. Mutation of the threonine 75 residue of chicken Ets‐2 conserved in the Pointed group of the Ets family proteins abrogated the ability of Ets‐2 to collaborate with EGF. Ets‐1 and Ets‐2 were highly expressed in invasive breast tumor cell lines. Our results suggest that Ets‐1 and Ets‐2 provide the link connecting EGF stimuli with activation of uPA and 92 kDa type IV collagenase promoters and may contribute to invasion phenotypes. Int. J. Cancer 77:128–137, 1998.© 1998 Wiley‐Liss, Inc.
doi_str_mv 10.1002/(SICI)1097-0215(19980703)77:1<128::AID-IJC20>3.0.CO;2-9
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79950316</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>79950316</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5410-a46fbdb9d7f21658a0d27b0e7e8c7bdaff78c4ecd081fc1b7e3908ad8a1991553</originalsourceid><addsrcrecordid>eNqFkc1u1DAUhSMEKtPCIyB5gVC7yHDt_DgeEFUVCgRVmgVFsLtyHKc1ZOJgZ1p1xyPwErwYT4JnJswGJFbXvj73-NhfFJ1SmFMA9vz4Q1VWJxQEj4HR7JgKUQCH5ITzBX1JWbFYnFWv4-p9yeBVMod5uXzBYnEvmu1n7kez4AQxp0n-MDr0_gsApRmkB9GByBORQjqLfl5ea3I--l_ff1Ai-2ZaMzI62XvlzDAa25NWqtE6T0IxN3LUZAxjg7MrO-rQbq0jpr-RPmjDtPTeKhNkDVk7-9X00uutubJdJ6_0dh-K9mGKOO0H24fOaIkeTKPdSnbkytnb8Xq6-FH0oJWd14-nehR9fHN-Wb6LL5Zvq_LsIlZZSiGWad7WTS0a3jKaZ4WEhvEaNNeF4nUj25YXKtWqgYK2itZcJwIK2RQyfC_NsuQoerbzDU_7ttZ-xJXxSofQvbZrj1yIDBKaB-GnnVA5673TLQ7OrKS7Qwq4AYi4AYgbGLiBgX8AIudIMQBEDABxCxATBCyXyFAE5ydThHW90s3edyIWzp9O59Ir2bUBkzJ-L2Msh1RAkH3eyW5Np-_-SvffcP_KtmskvwG0MMoN</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>79950316</pqid></control><display><type>article</type><title>The Ets‐1 and Ets‐2 transcription factors activate the promoters for invasion‐associated urokinase and collagenase genes in response to epidermal growth factor</title><source>Wiley-Blackwell Journals</source><source>MEDLINE</source><source>EZB Electronic Journals Library</source><creator>Watabe, Tetsuya ; Yoshida, Koichi ; Shindoh, Masanobu ; Kaya, Mitsunori ; Fujikawa, Keiko ; Sato, Hiroshi ; Seiki, Motoharu ; Ishii, Seiichi ; Fujinaga, Kei</creator><creatorcontrib>Watabe, Tetsuya ; Yoshida, Koichi ; Shindoh, Masanobu ; Kaya, Mitsunori ; Fujikawa, Keiko ; Sato, Hiroshi ; Seiki, Motoharu ; Ishii, Seiichi ; Fujinaga, Kei</creatorcontrib><description>Urokinase plasminogen activator (uPA) has been associated with invasion and metastasis in breast cancer. The expression of uPA and 92 kDa type IV collagenase (gelatinase B/MMP‐9) is regulated by growth factors, receptor‐type tyrosine kinases and cytoplasmic oncoproteins. Here, we have identified transcriptional requirements for the induction of uPA and 92 kDa type IV collagenase by epidermal growth factor (EGF). EGF stimulates the motile and invasive activities specifically in the ErbB‐2‐overexpressing SK‐BR‐3 cells. Expression of extracellular matrix‐degrading proteases including type I collagenase/MMP‐1, 92 kDa type IV collagenase/MMP‐9, uPA and uPA receptor were induced. EGF also transiently stimulated expression of the transcription factors Ets‐1 and Ets‐2. Reporter transfection assays revealed the activation of uPA and MMP‐9 collagenase promoters by EGF and the requirement of each of the composite Ets and AP‐1 transcription factor binding sites for an EGF response. Most notably, transfections with the Ets‐1 and Ets‐2 expression vectors potentiated uPA and MMP‐9 promoter activation in response to EGF. Mutation of the threonine 75 residue of chicken Ets‐2 conserved in the Pointed group of the Ets family proteins abrogated the ability of Ets‐2 to collaborate with EGF. Ets‐1 and Ets‐2 were highly expressed in invasive breast tumor cell lines. Our results suggest that Ets‐1 and Ets‐2 provide the link connecting EGF stimuli with activation of uPA and 92 kDa type IV collagenase promoters and may contribute to invasion phenotypes. Int. J. Cancer 77:128–137, 1998.© 1998 Wiley‐Liss, Inc.</description><identifier>ISSN: 0020-7136</identifier><identifier>EISSN: 1097-0215</identifier><identifier>DOI: 10.1002/(SICI)1097-0215(19980703)77:1&lt;128::AID-IJC20&gt;3.0.CO;2-9</identifier><identifier>PMID: 9639404</identifier><identifier>CODEN: IJCNAW</identifier><language>eng</language><publisher>New York: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Biological and medical sciences ; Breast Neoplasms - genetics ; Breast Neoplasms - pathology ; Collagenases - genetics ; Dissemination ; DNA-Binding Proteins ; Epidermal Growth Factor - pharmacology ; Female ; Gene Expression Regulation, Neoplastic - drug effects ; Humans ; Medical sciences ; Neoplasm Invasiveness ; Promoter Regions, Genetic ; Proto-Oncogene Protein c-ets-1 ; Proto-Oncogene Protein c-ets-2 ; Proto-Oncogene Proteins - genetics ; Proto-Oncogene Proteins c-ets ; Repressor Proteins ; Trans-Activators - genetics ; Transcription Factors - genetics ; Tumor cell ; Tumor Cells, Cultured ; Tumors ; Urokinase-Type Plasminogen Activator - genetics</subject><ispartof>International journal of cancer, 1998-07, Vol.77 (1), p.128-137</ispartof><rights>Copyright © 1998 Wiley‐Liss, Inc.</rights><rights>1998 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c5410-a46fbdb9d7f21658a0d27b0e7e8c7bdaff78c4ecd081fc1b7e3908ad8a1991553</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2F%28SICI%291097-0215%2819980703%2977%3A1%3C128%3A%3AAID-IJC20%3E3.0.CO%3B2-9$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2F%28SICI%291097-0215%2819980703%2977%3A1%3C128%3A%3AAID-IJC20%3E3.0.CO%3B2-9$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2260490$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9639404$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Watabe, Tetsuya</creatorcontrib><creatorcontrib>Yoshida, Koichi</creatorcontrib><creatorcontrib>Shindoh, Masanobu</creatorcontrib><creatorcontrib>Kaya, Mitsunori</creatorcontrib><creatorcontrib>Fujikawa, Keiko</creatorcontrib><creatorcontrib>Sato, Hiroshi</creatorcontrib><creatorcontrib>Seiki, Motoharu</creatorcontrib><creatorcontrib>Ishii, Seiichi</creatorcontrib><creatorcontrib>Fujinaga, Kei</creatorcontrib><title>The Ets‐1 and Ets‐2 transcription factors activate the promoters for invasion‐associated urokinase and collagenase genes in response to epidermal growth factor</title><title>International journal of cancer</title><addtitle>Int J Cancer</addtitle><description>Urokinase plasminogen activator (uPA) has been associated with invasion and metastasis in breast cancer. The expression of uPA and 92 kDa type IV collagenase (gelatinase B/MMP‐9) is regulated by growth factors, receptor‐type tyrosine kinases and cytoplasmic oncoproteins. Here, we have identified transcriptional requirements for the induction of uPA and 92 kDa type IV collagenase by epidermal growth factor (EGF). EGF stimulates the motile and invasive activities specifically in the ErbB‐2‐overexpressing SK‐BR‐3 cells. Expression of extracellular matrix‐degrading proteases including type I collagenase/MMP‐1, 92 kDa type IV collagenase/MMP‐9, uPA and uPA receptor were induced. EGF also transiently stimulated expression of the transcription factors Ets‐1 and Ets‐2. Reporter transfection assays revealed the activation of uPA and MMP‐9 collagenase promoters by EGF and the requirement of each of the composite Ets and AP‐1 transcription factor binding sites for an EGF response. Most notably, transfections with the Ets‐1 and Ets‐2 expression vectors potentiated uPA and MMP‐9 promoter activation in response to EGF. Mutation of the threonine 75 residue of chicken Ets‐2 conserved in the Pointed group of the Ets family proteins abrogated the ability of Ets‐2 to collaborate with EGF. Ets‐1 and Ets‐2 were highly expressed in invasive breast tumor cell lines. Our results suggest that Ets‐1 and Ets‐2 provide the link connecting EGF stimuli with activation of uPA and 92 kDa type IV collagenase promoters and may contribute to invasion phenotypes. Int. J. Cancer 77:128–137, 1998.© 1998 Wiley‐Liss, Inc.</description><subject>Biological and medical sciences</subject><subject>Breast Neoplasms - genetics</subject><subject>Breast Neoplasms - pathology</subject><subject>Collagenases - genetics</subject><subject>Dissemination</subject><subject>DNA-Binding Proteins</subject><subject>Epidermal Growth Factor - pharmacology</subject><subject>Female</subject><subject>Gene Expression Regulation, Neoplastic - drug effects</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Neoplasm Invasiveness</subject><subject>Promoter Regions, Genetic</subject><subject>Proto-Oncogene Protein c-ets-1</subject><subject>Proto-Oncogene Protein c-ets-2</subject><subject>Proto-Oncogene Proteins - genetics</subject><subject>Proto-Oncogene Proteins c-ets</subject><subject>Repressor Proteins</subject><subject>Trans-Activators - genetics</subject><subject>Transcription Factors - genetics</subject><subject>Tumor cell</subject><subject>Tumor Cells, Cultured</subject><subject>Tumors</subject><subject>Urokinase-Type Plasminogen Activator - genetics</subject><issn>0020-7136</issn><issn>1097-0215</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc1u1DAUhSMEKtPCIyB5gVC7yHDt_DgeEFUVCgRVmgVFsLtyHKc1ZOJgZ1p1xyPwErwYT4JnJswGJFbXvj73-NhfFJ1SmFMA9vz4Q1VWJxQEj4HR7JgKUQCH5ITzBX1JWbFYnFWv4-p9yeBVMod5uXzBYnEvmu1n7kez4AQxp0n-MDr0_gsApRmkB9GByBORQjqLfl5ea3I--l_ff1Ai-2ZaMzI62XvlzDAa25NWqtE6T0IxN3LUZAxjg7MrO-rQbq0jpr-RPmjDtPTeKhNkDVk7-9X00uutubJdJ6_0dh-K9mGKOO0H24fOaIkeTKPdSnbkytnb8Xq6-FH0oJWd14-nehR9fHN-Wb6LL5Zvq_LsIlZZSiGWad7WTS0a3jKaZ4WEhvEaNNeF4nUj25YXKtWqgYK2itZcJwIK2RQyfC_NsuQoerbzDU_7ttZ-xJXxSofQvbZrj1yIDBKaB-GnnVA5673TLQ7OrKS7Qwq4AYi4AYgbGLiBgX8AIudIMQBEDABxCxATBCyXyFAE5ydThHW90s3edyIWzp9O59Ir2bUBkzJ-L2Msh1RAkH3eyW5Np-_-SvffcP_KtmskvwG0MMoN</recordid><startdate>19980703</startdate><enddate>19980703</enddate><creator>Watabe, Tetsuya</creator><creator>Yoshida, Koichi</creator><creator>Shindoh, Masanobu</creator><creator>Kaya, Mitsunori</creator><creator>Fujikawa, Keiko</creator><creator>Sato, Hiroshi</creator><creator>Seiki, Motoharu</creator><creator>Ishii, Seiichi</creator><creator>Fujinaga, Kei</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley-Liss</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19980703</creationdate><title>The Ets‐1 and Ets‐2 transcription factors activate the promoters for invasion‐associated urokinase and collagenase genes in response to epidermal growth factor</title><author>Watabe, Tetsuya ; Yoshida, Koichi ; Shindoh, Masanobu ; Kaya, Mitsunori ; Fujikawa, Keiko ; Sato, Hiroshi ; Seiki, Motoharu ; Ishii, Seiichi ; Fujinaga, Kei</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5410-a46fbdb9d7f21658a0d27b0e7e8c7bdaff78c4ecd081fc1b7e3908ad8a1991553</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Biological and medical sciences</topic><topic>Breast Neoplasms - genetics</topic><topic>Breast Neoplasms - pathology</topic><topic>Collagenases - genetics</topic><topic>Dissemination</topic><topic>DNA-Binding Proteins</topic><topic>Epidermal Growth Factor - pharmacology</topic><topic>Female</topic><topic>Gene Expression Regulation, Neoplastic - drug effects</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Neoplasm Invasiveness</topic><topic>Promoter Regions, Genetic</topic><topic>Proto-Oncogene Protein c-ets-1</topic><topic>Proto-Oncogene Protein c-ets-2</topic><topic>Proto-Oncogene Proteins - genetics</topic><topic>Proto-Oncogene Proteins c-ets</topic><topic>Repressor Proteins</topic><topic>Trans-Activators - genetics</topic><topic>Transcription Factors - genetics</topic><topic>Tumor cell</topic><topic>Tumor Cells, Cultured</topic><topic>Tumors</topic><topic>Urokinase-Type Plasminogen Activator - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Watabe, Tetsuya</creatorcontrib><creatorcontrib>Yoshida, Koichi</creatorcontrib><creatorcontrib>Shindoh, Masanobu</creatorcontrib><creatorcontrib>Kaya, Mitsunori</creatorcontrib><creatorcontrib>Fujikawa, Keiko</creatorcontrib><creatorcontrib>Sato, Hiroshi</creatorcontrib><creatorcontrib>Seiki, Motoharu</creatorcontrib><creatorcontrib>Ishii, Seiichi</creatorcontrib><creatorcontrib>Fujinaga, Kei</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Watabe, Tetsuya</au><au>Yoshida, Koichi</au><au>Shindoh, Masanobu</au><au>Kaya, Mitsunori</au><au>Fujikawa, Keiko</au><au>Sato, Hiroshi</au><au>Seiki, Motoharu</au><au>Ishii, Seiichi</au><au>Fujinaga, Kei</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Ets‐1 and Ets‐2 transcription factors activate the promoters for invasion‐associated urokinase and collagenase genes in response to epidermal growth factor</atitle><jtitle>International journal of cancer</jtitle><addtitle>Int J Cancer</addtitle><date>1998-07-03</date><risdate>1998</risdate><volume>77</volume><issue>1</issue><spage>128</spage><epage>137</epage><pages>128-137</pages><issn>0020-7136</issn><eissn>1097-0215</eissn><coden>IJCNAW</coden><abstract>Urokinase plasminogen activator (uPA) has been associated with invasion and metastasis in breast cancer. The expression of uPA and 92 kDa type IV collagenase (gelatinase B/MMP‐9) is regulated by growth factors, receptor‐type tyrosine kinases and cytoplasmic oncoproteins. Here, we have identified transcriptional requirements for the induction of uPA and 92 kDa type IV collagenase by epidermal growth factor (EGF). EGF stimulates the motile and invasive activities specifically in the ErbB‐2‐overexpressing SK‐BR‐3 cells. Expression of extracellular matrix‐degrading proteases including type I collagenase/MMP‐1, 92 kDa type IV collagenase/MMP‐9, uPA and uPA receptor were induced. EGF also transiently stimulated expression of the transcription factors Ets‐1 and Ets‐2. Reporter transfection assays revealed the activation of uPA and MMP‐9 collagenase promoters by EGF and the requirement of each of the composite Ets and AP‐1 transcription factor binding sites for an EGF response. Most notably, transfections with the Ets‐1 and Ets‐2 expression vectors potentiated uPA and MMP‐9 promoter activation in response to EGF. Mutation of the threonine 75 residue of chicken Ets‐2 conserved in the Pointed group of the Ets family proteins abrogated the ability of Ets‐2 to collaborate with EGF. Ets‐1 and Ets‐2 were highly expressed in invasive breast tumor cell lines. Our results suggest that Ets‐1 and Ets‐2 provide the link connecting EGF stimuli with activation of uPA and 92 kDa type IV collagenase promoters and may contribute to invasion phenotypes. Int. J. Cancer 77:128–137, 1998.© 1998 Wiley‐Liss, Inc.</abstract><cop>New York</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>9639404</pmid><doi>10.1002/(SICI)1097-0215(19980703)77:1&lt;128::AID-IJC20&gt;3.0.CO;2-9</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0020-7136
ispartof International journal of cancer, 1998-07, Vol.77 (1), p.128-137
issn 0020-7136
1097-0215
language eng
recordid cdi_proquest_miscellaneous_79950316
source Wiley-Blackwell Journals; MEDLINE; EZB Electronic Journals Library
subjects Biological and medical sciences
Breast Neoplasms - genetics
Breast Neoplasms - pathology
Collagenases - genetics
Dissemination
DNA-Binding Proteins
Epidermal Growth Factor - pharmacology
Female
Gene Expression Regulation, Neoplastic - drug effects
Humans
Medical sciences
Neoplasm Invasiveness
Promoter Regions, Genetic
Proto-Oncogene Protein c-ets-1
Proto-Oncogene Protein c-ets-2
Proto-Oncogene Proteins - genetics
Proto-Oncogene Proteins c-ets
Repressor Proteins
Trans-Activators - genetics
Transcription Factors - genetics
Tumor cell
Tumor Cells, Cultured
Tumors
Urokinase-Type Plasminogen Activator - genetics
title The Ets‐1 and Ets‐2 transcription factors activate the promoters for invasion‐associated urokinase and collagenase genes in response to epidermal growth factor
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T15%3A04%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Ets%E2%80%901%20and%20Ets%E2%80%902%20transcription%20factors%20activate%20the%20promoters%20for%20invasion%E2%80%90associated%20urokinase%20and%20collagenase%20genes%20in%20response%20to%20epidermal%20growth%20factor&rft.jtitle=International%20journal%20of%20cancer&rft.au=Watabe,%20Tetsuya&rft.date=1998-07-03&rft.volume=77&rft.issue=1&rft.spage=128&rft.epage=137&rft.pages=128-137&rft.issn=0020-7136&rft.eissn=1097-0215&rft.coden=IJCNAW&rft_id=info:doi/10.1002/(SICI)1097-0215(19980703)77:1%3C128::AID-IJC20%3E3.0.CO;2-9&rft_dat=%3Cproquest_cross%3E79950316%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=79950316&rft_id=info:pmid/9639404&rfr_iscdi=true